Clinical trial
Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease
NCT00103714 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00103714 |
|---|---|
| Title | Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease |
| Official title | A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients With Cystic Fibrosis Lung Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) |
| Enrollment | 72 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Feb 15, 2005 |
| Last update posted | Oct 20, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: